SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH M impact

EU Approves AstraZeneca’s Klygefa

The EU approved AstraZeneca’s Klygefa (gefurulimab).

Story updates

07:01:38 AM UTC
SquawkNews
... AstraZeneca Approval based on PREVAIL Phase III trial demonstrating statistically significant an
07:19:18 AM UTC
SquawkNews
By Adam WhittakerAstraZeneca's autoimmune drug Klygefa has been approved in the U.S. and the European Union to treat adults with generalized myasthenia gravis.In separate releases Monday, the U.K. pharmaceutical company said the approvals follow Phase 3 trials that showed the drug delivered a signi…

Related stories